Source:http://linkedlifedata.com/resource/pubmed/id/10231542
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
1999-6-1
|
pubmed:abstractText |
In this study, we used maleimidobutyrylbiocytin to examine possible alteration that may occur in the redox state of the insulin receptor (IR) sulfhydryl groups in response to reduced glutathione (GSH) or N-acetyl-L-cysteine (NAC). Short-term treatment of intact cells expressing large numbers of IR with GSH or NAC led to a rapid and reversible reduction of IR alpha-subunit disulfides, without affecting the receptor beta-subunit thiol reactivity. The overall integrity of the oligomeric structure of IR was maintained, indicating that neither class I nor class II disulfides were targeted by these agents. Similar findings were obtained in cells transfected with IR mutants lacking cysteine524, one of the class I disulfides that link the two IR alpha-subunits. Membrane-associated thiols did not participate in GSH- or NAC-mediated reduction of IR alpha-subunit disulfides. No difference in insulin binding was observed in GSH-treated cells; however, ligand-mediated increases in IR autophosphorylation, tyrosine phosphorylation of cellular substrates, and dual phosphorylation of the downstream target mitogen-activated protein kinase were inhibited at concentrations of GSH (10 mM or greater) that yielded a significant increase in IR alpha-subunit thiol reactivity. GSH did not affect IR signaling in the absence of insulin. Our results provide the first evidence that the IR alpha-subunit contains a select group of disulfides whose redox status can be rapidly altered by the reducing agents GSH and NAC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcysteine,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfhydryl Compounds
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5896-904
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10231542-Acetylcysteine,
pubmed-meshheading:10231542-Animals,
pubmed-meshheading:10231542-CHO Cells,
pubmed-meshheading:10231542-Carcinoma, Hepatocellular,
pubmed-meshheading:10231542-Cricetinae,
pubmed-meshheading:10231542-Culture Media,
pubmed-meshheading:10231542-Glutathione,
pubmed-meshheading:10231542-Humans,
pubmed-meshheading:10231542-Oxidation-Reduction,
pubmed-meshheading:10231542-Protein Binding,
pubmed-meshheading:10231542-Rats,
pubmed-meshheading:10231542-Receptor, Insulin,
pubmed-meshheading:10231542-Sulfhydryl Compounds,
pubmed-meshheading:10231542-Time Factors,
pubmed-meshheading:10231542-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Reversible change in thiol redox status of the insulin receptor alpha-subunit in intact cells.
|
pubmed:affiliation |
Diabetes Section, Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224-6825, USA.
|
pubmed:publicationType |
Journal Article
|